ProCE Banner Activity

Future Directions: The Evolving Role of PI3K Inhibitors for Patients With FL

Slideset Download
Download this slideset on the evolving role of PI3K inhibitors for patients with relapsed and refractory follicular lymphoma.

Released: June 17, 2021

Expiration: June 16, 2022

No longer available for credit.

Share

Faculty

John M. Burke

John M. Burke, MD

Associate Chair
US Oncology Hematology Research Program
Rocky Mountain Cancer Centers
Aurora, Colorado

Provided by

Provided by Clinical Care Options, LLC
ProCE Banner

Supporters

Supported by educational grants from

Bayer Healthcare Pharma

TG Therapeutics

Faculty Disclosure

Primary Author

John M. Burke, MD

Associate Chair
US Oncology Hematology Research Program
Rocky Mountain Cancer Centers
Aurora, Colorado